Xiflam™

· Inflammx Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Xiflam™, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long COVID (LC) [Phase 2]

See pricing